The Best Place to Buy Market Research Reports - Market Research Engine (MRE)

  What Are Ophthalmic Viscoelastic Devices (OVDs)? Ophthalmic Viscoelastic Devices (OVDs) are specialized gel-like materials used during eye surgeries — particularly intraocular procedures — to maintain space within the eye, offer protection to delicate ocular tissues, and support better surgical outcomes. According to the report, their effectiveness has contributed to increased success rates in procedures such as lens implantation and cataract surgeries. Market Forecast & Key Numbers The global OVD market Size is projected to reach around USD 1,900 million by 2028 . The forecast is based on a compound annual growth rate (CAGR) of 10.5% over the period 2023–2028.   Major Market Drivers The growth of the OVD market is driven by: ·        An increasing number of cataract and glaucoma surgeries , which depend on viscoelastic devices to ensure safe and effective outcomes. ·     ...

  The global dental cleansing tablet market is witnessing steady growth, driven by increasing awareness around oral hygiene, rising denture use, and the growing accessibility of products through online and offline channels. MarketResearchEngine’s report provides an in-depth look at the key drivers, market segments, and competitive landscape shaping this industry. Market Size & Growth Forecast The market is projected to exceed USD 350 million by 2028 , with a compound annual growth rate (CAGR) of 6.1% over the forecast period. This reflects a strong and sustained demand for dental cleansing tablets in both developed and emerging markets. Key Market Drivers Rising Demand for Denture Care A significant portion of the demand is driven by removable partial dentures . These are popular because they are easier to insert and remove, increasing the need for reliable cleansing solutions. As the population ages, the number of denture users is expected to grow, pushing demand further. Gr...

  Across the world, urological conditions—ranging from benign prostate enlargement to lower urinary tract symptoms—are driving demand for targeted medications. According to the report, the global urology drugs market is expected to reach approximately US $6.40 billion by 2028 , growing at a compound annual growth rate (CAGR) of about 6.4% from 2023 to 2028. What’s Driving Growth? Several key factors are underpinning this market’s expansion: Ageing populations & rising incidence of urological disorders As people live longer, conditions such as benign prostatic hyperplasia (BPH), overactive bladder, and lower urinary tract symptoms become more prevalent. The report notes that lower urinary tract symptoms (LUTS) “are not a disease that can affect survival, but are closely related to quality of life and form a huge drug market worldwide.” Growing awareness & diagnosis More men are seeking treatment for urological symptoms, and as diagnostics improve and awareness rises, more ...